Portfolio / Cytura

Cytura.gif


Genomic instability is a major problem in cancer progression and therapy resistance. Cytura Therapeutics is aiming at finding a solution for this, by targeting genomic instability both as a stand-alone therapy, as well as in combination therapy to overcome resistance or avoid relapse. This will help make cancer treatment more effective and improve the lives of patients worldwide.

Company: Cytura

Fund: II

Status: Active

Team member:

Harrold van Barlingen

19.jpg
 

Technology:

Therapeutics

logo therapeutics.jpg